Cite

HARVARD Citation

    Toyoda, H. et al. (2021). Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice. Hepatology. 74 (2), pp. 656-666. [Online]. 
  
Back to record